| Potent Ca(V)3.2 channel inhibitors exert analgesic effects in acute and chronic pain models |
| Kamau, PM; Li, H; Yao, ZH; Han, YL; Luo, AN; Zhang, H; Boonyarat, C; Yenjai, C; Mwangi, J; Zeng, L; Yang, SL; Lai, R; Luo, L
|
| 2022
|
| 发表期刊 | BIOMEDICINE & PHARMACOTHERAPY
 |
| ISSN | 0753-3322
|
| 卷号 | 153 |
| 摘要 | Pain is the most common presenting physical symptom and a primary reason for seeking medical care, which chronically affects people's mental health and social life. Ca(V)3.2 channel plays an essential role in the peripheral processing maintenance of pain states. This study was designed to identify novel drug candidates targeting the Ca(V)3.2 channel. Whole-cell patch-clamp, cellular thermal shift assay, FlexStation, in vivo and in vitro Ca(V)3.2 knock-down, site-directed mutagenesis, and double-mutant cycle analysis were employed to explore the pain related receptors and ligand-receptor direct interaction. We found that toddaculin efficiently inhibits the Ca(V)3.2 channel and significantly reduced the excitability of dorsal root ganglion neurons and pain behaviors. The Carbonyl group of coumarins directly interacts with the pore domain of Ca(V)3.2 via van der Waals (VDW) force. Docking with binding pockets further led us to identify glycycoumarin, which exhibited more potent inhibition on the Ca(V)3.2 channel and better analgesic activity than the parent compound. Toddaculin and its analog showed beneficial therapeutic effects in pain models. Toddaculin binding pocket on Ca(V)3.2 might be a promising docking site for the design of drugs. |
| 收录类别 | sci
|
| 语种 | 英语
|
| 文献类型 | 期刊论文
|
| 条目标识符 | http://ir.kiz.ac.cn/handle/152453/13220
|
| 专题 | 科研部门_天然药物功能蛋白质学科组（赖仞）
|
推荐引用方式
GB/T 7714 |
Kamau, PM,Li, H,Yao, ZH,et al. Potent Ca(V)3.2 channel inhibitors exert analgesic effects in acute and chronic pain models[J]. BIOMEDICINE & PHARMACOTHERAPY,2022,153.
|
| APA |
Kamau, PM.,Li, H.,Yao, ZH.,Han, YL.,Luo, AN.,...&Luo, L.(2022).Potent Ca(V)3.2 channel inhibitors exert analgesic effects in acute and chronic pain models.BIOMEDICINE & PHARMACOTHERAPY,153.
|
| MLA |
Kamau, PM,et al."Potent Ca(V)3.2 channel inhibitors exert analgesic effects in acute and chronic pain models".BIOMEDICINE & PHARMACOTHERAPY 153(2022).
|
修改评论